Supercritical Antioxidants
Natural health product licensed in Canada
- Licence holder
- New Chapter Inc
- NPN or DIN-HM
- 80006052
- Status
- Inactive licence
- Licence date
- 6 June 2008
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zingiber officinale Source : Rhizome(s) Extraction ratio : 4.5:1 Dry plant equivalent : 33.75 mg | 7.5 mg | Not calculated |
| Curcuma longa Source : Rhizome(s) Potency : 11 % Curcumin | 190 mg | Not calculated |
| Petroselinum crispum Source : Graine(s) Extraction ratio : 8:1 Dry plant equivalent : 60 mg | 7.5 mg | Not calculated |
| Mentha piperita Source : Feuille(s) Potency : 35 % Menthol | 7.5 mg | Not calculated |
Non-medicinal ingredients
huile d'olive, Gélatine, Cire d'abeille jaune, Carob, Eau purifiée, Glycérine végétale, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Antioxidents for the maintenace of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if you have a history of gallstones, biliary tract obstructions and/or stomach ulcers, gallbladder, or bile-duct obstruction, hiatal hernia, acid reflex, liver disorder, severe circulatory disorders or develop symptoms of liver trouble. Consult a health care practitioner if you are taking blood-thinners or chemotherapeutic agents. Discontinue if hypersensitivity occurs.
- Contre-indications
Do not use if you are pregnangt or breastfeeding.
Source
Official Health Canada record, licence 80006052
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.